retatrutide glp-1 gip glucagon agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research The novel GIP, GLP‐1 and

Empagliflozin and cardiovascular outcomes in Asian patients with type 2 diabetes and established cardiovascular diseaseresults from EMPA-REG OUTCOME

The GLP-1 pill tended toward slightly better blood sugar reduction

This dual impact includes mental feelings of fullness through hormonal mimicry and physical fullness due to slower digestion, making it a highly effective option for weight loss

No labs or video consults unless required by state law

30 , 61429 doi: in press (2016)

Comparing Retatrutide Benefits to Other Treatments Understanding how Retatrutide compares to other options helps you discuss choices with your healthcare provider